Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes

NCT06532682 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Kidney Disease
Type 1 Diabetes

Interventions

DRUG: dapagliflozin
DRUG: ACE inhibitor

Sponsor

The First Affiliated Hospital with Nanjing Medical University